Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

GECCO - Genetics and Epidemiology of Colorectal Cancer Consortium

The Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) is a consortium made up of scientists from North America, Australia, Asia and Europe with the goal of identifying genetic variants for colorectal cancer risk and prognosis also by molecular subtypes, and investigating how these variants interact with environmental factors. The coordinating center at the Fred Hutchinson Cancer Research Center harmonizes data from 70 epidemiological studies on colorectal cancer, comprising in total over 130,000 participants.

The DACHS study participates in this consortium by providing clinical and epidemiologic data as well as DNA samples for genotyping. Using the rich data source made available by GECCO, our group leads several studies that mainly focus on the interplay between menopausal hormone therapy and genetic susceptibility in relation to risk of colorectal cancer. Both conventional and functionally-informed genome-wide analyses of gene-environment interactions with menopausal hormone therapy will be carried out as well as a pathway analysis of hormone-metabolism pathways.

National Cancer Institute, NIH, U.S. Department of Health and Human Services (U01 CA137088, R01CA201407)

to top
powered by webEdition CMS